Odonate Therapeutics, Inc.
Extract: Bylaws Amended/Restated (Plain English Desc) from a 8-K on 06/24/2019   Download
SEC Document
SEC Filing

On June 20, 2019, the Board of Directors (the “Board”) of Odonate Therapeutics, Inc. (the “Company”) amended its bylaws by approving and adopting the First Amended and Restated Bylaws of the Company (the “Amended Bylaws”). The Amended Bylaws change the Company’s vote requirement in uncontested elections of directors from a plurality vote standard to a majority vote standard. Using the plurality vote standard, there is no minimum number of votes required for a director to be elected to the Board; whereas, using the majority vote standard, the affirmative vote of a majority of votes cast is required to elect a director. The Company believes that the majority vote standard better aligns its interests with those of its stockholders.